Tracy Saxton

Tracy Saxton

Chief Executive Officer at
Aucupo Biosciences, Inc.
Health Technology
Consumer Services
Finance

Profile

Tracy Saxton is the founder of Aucupo Biosciences, Inc. She is currently a Fellow at The Damon Runyon Cancer Research Foundation.
Previously, she held positions as a Director at Millendo Therapeutics US, Inc., PanOptica, Inc., and MISSION Therapeutics Ltd. She was also a Principal at Amgen, Inc., Geron Corp., Tularik, Inc., Threshold Pharmaceuticals, Inc., Cyterix Pharmaceuticals, Inc., and Rempex Pharmaceuticals, Inc. Additionally, she served as an Investment Director at Roche Ventures from 2015 to 2017 and as a Managing Director at Dolby Family Ventures LLC from 2020 to 2022.
She was a Director at Vaxcyte, Inc., Entasis Therapeutics, Inc., and Lengo Therapeutics, Inc. from 2017 to 2017, 2019 to 2021, and 2017 to 2017, respectively.
She also worked as a Managing Partner at Pivotal Bioventure Partners Investment Advisor LLC in 2017.
Dr. Saxton holds an MBA from The Trustees of Columbia University in The City of New York, an undergraduate degree from Simon Fraser University, and a doctorate from the University of Toronto.

Tracy Saxton active positions

CompaniesPositionStart
Corporate Officer/Principal -
Chief Executive Officer -

Former positions of Tracy Saxton

CompaniesPositionEnd
Private Equity Investor 30/06/2022
Chief Executive Officer -
Private Equity Investor 31/12/2017
Director/Board Member 01/12/2017
Private Equity Investor 31/01/2017
See the detail of Tracy Saxton's experience

Training of Tracy Saxton

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

54

1st degree connections

20

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies20

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Finance

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Finance

Health Technology

Health Technology